XIAP and hematopoietic and lymphoid cell neoplasm: Even though MiHA can originate from non-synonymous SNVs in exons or in non-coding regions (32, 59, 60), we will focus herein on exonic MiHAs because they are easier to identify than those generated from atypical transcripts, and probably sufficient to enable immunotherapy of hematologic cancers.